Integra Lifesciences Holdings (IART) Amortization of Deferred Charges (2009 - 2019)

Integra Lifesciences Holdings has disclosed Amortization of Deferred Charges across 11 years of filings, most recently posting $1.3 million for Q4 2019.

• Amortization of Deferred Charges for Q4 2019 came in at $1.3 million, down 0.84% year-over-year; the trailing twelve-month figure through Dec 2019 was $5.4 million (down 14.04% YoY), and the FY2019 annual result was $5.4 million, down 14.04% from the prior year.
• Amortization of Deferred Charges came in at $1.3 million for Q4 2019 at Integra Lifesciences Holdings, down from $1.4 million in the prior quarter.
• In the past five years, Amortization of Deferred Charges ranged from a high of $2.1 million in Q2 2018 to a low of $387000.0 in Q3 2016.
• The 5-year median for Amortization of Deferred Charges is $763000.0 (2016), against an average of $958750.0.
• Across the five-year window, Amortization of Deferred Charges tumbled 36.94% in 2017 and surged 446.8% in 2018, its largest moves.
• Integra Lifesciences Holdings' Amortization of Deferred Charges stood at $619000.0 in 2015, then soared by 46.37% to $906000.0 in 2016, then surged by 70.42% to $1.5 million in 2017, then decreased by 14.7% to $1.3 million in 2018, then declined by 0.84% to $1.3 million in 2019.
• The last three Amortization of Deferred Charges figures came in at $1.3 million (Q4 2019), $1.4 million (Q3 2019), and $1.4 million (Q2 2019), per Business Quant data.